Search clinical trials for: Tumor Regression

Total 32724 results

Medical University of Lublin
Erasmus Medical Center; Jagiellonian University; Ohio State University; Poznan...

Recruiting

MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment (MOONRISE)

Gastric Cancer | Malnutrition | Gastric Adenocarcinoma | Cachexia

Poland
Zhejiang Cancer Hospital

Recruiting

DLCS for Predicting Neoadjuvant Chemotherapy Response

Gastric Cancer | Deep Learning | Neoadjuvant Chemotherapy | CT Images | Tumor Regression Grade

China
Ruhr University of Bochum

Recruiting

DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections (HPV-VG1)

HPV Infection | Cervix Dysplasia

Germany
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia
Daping Hospital and the Research Institute of Surgery...

Completed

PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

Tumor Regression Grade

China
Sumitomo Pharma America, Inc.
Syneos Health

Terminated

A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Neoplasms

United States
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR). (PAPILOBSGR)

Papillomavirus Infections

Greece
Zealand University Hospital
Danish Cancer Society; University Hospital Southampton NHS Foundation Trust; Region... and other collaborators

Active, not recruiting

Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer (Neo-train)

Breast Cancer

Denmark
National Cancer Institute (NCI)

Terminated

Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Cholangiocarcinoma | Bile Duct Cancer | Biliary Tract Neoplasms | Biliary Cancer

United States
Woman's
Pfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...

Withdrawn

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer (METBC)

Insulin Resistance | Breast Cancer Stage | Racial Bias

United States
Centre Hospitalier Régional d'Orléans

Completed

Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance (PAPILOCARE)

Human Papilloma Virus Infection | Squamous Intraepithelial Lesions of the Cervix | Cervix Lesion

France
Indiana University

Active, not recruiting

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Melanoma; Renal Cell Carcinoma

United States
Fujian Medical University

Completed

Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy

Gastric Cancer

China
National Cancer Institute (NCI)

Completed

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive

Melanoma | Cervical Cancer | Breast Cancer | Renal Cancer | Urothelial Cancer

United States
Novartis Pharmaceuticals

Completed

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma

United States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
Klinik Favoriten

Completed

Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer

Gastrointestinal Neoplasm

Austria
Novartis Pharmaceuticals

Completed

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Advanced Solid and Hematological TP53wt Tumors

France, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
National Cancer Institute (NCI)

Completed

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

Melanoma | Breast Cancer | Non-Small Cell Lung Cancer | Meningioma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Terminated

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Melanoma | Colon Cancer | Gastrointestinal Cancer | Hepatocellular Cancer | Genitourinary Cancer

United States
KU Leuven

Unknown

Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery (IOTA7)

Patients With Adnexal Mass Prior to Surgery

Belgium
Sixth Affiliated Hospital, Sun Yat-sen University
Sir Run Run Shaw Hospital; The Third Affiliated Hospital of Kunming Medical...

Unknown

RadioPathomics Artificial Intelligence Model to Predict Tumor Regression Grading in Locally Advanced Rectal Cancer (RPAI-TRG)

Rectal Cancer

China
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cell Cancer

United States
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN

Disease Progression | Papillomavirus Infections | High-Grade Squamous Intraepithelial Lesions | Neoplasm Regression, Spontaneous

Spain
Indiana University
Indiana University Health

Completed

Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors

Breast Cancer | Breast Neoplasms | Anxiety | Breast Carcinoma | Fear | Cancer of Breast | Malignant Tumor of Breast | Malignant Neoplasm of Breast | Mammary Cancer | Human Mammary Carcinoma | Mammary Neoplasm, Human | Mammary Carcinoma | Neoplasm Remission, Spontaneous | Spontaneous Neoplasm Regression | Regression,... and other conditions

United States
University Hospital, Strasbourg, France

Unknown

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Neuroma, Acoustic

France
Royal Marsden NHS Foundation Trust
Pelican Cancer Foundation

Unknown

Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (MARVEL)

Digestive System Diseases | Gastrointestinal Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Gastrointestinal Neoplasms | Digestive System Neoplasms | Intestinal Diseases | Colorectal Neoplasms | Intestinal Neoplasms | Rectal... and other conditions

United Kingdom
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)

Terminated

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Metastatic Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Terminated

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Terminated

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Metastatic Cancer

United States
National Cancer Institute (NCI)

Completed

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Melanoma | Skin Cancer

United States
National Cancer Institute (NCI)

Terminated

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Terminated

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

Metastatic Melanoma | Metastatic Renal Cancer

United States
National Cancer Institute (NCI)

Terminated

Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer

Metastatic Cancer

United States
NYU Langone Health

Completed

Inducing Systemic Immunity and Regressions in Metastatic Melanoma

Metastatic Malignant Melanoma
Sanofi

Completed

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Renal Impairment

United States
National Cancer Institute (NCI)

Completed

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Melanoma

United States
AGUNCO Obstetrics and Gynecology Centre

Completed

Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection

HPV Infection

Italy
National Cancer Institute (NCI)

Completed

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

Anti-p53 TCR-Gene

United States
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Breast Cancer | HER2-positive Breast Cancer | Circulating Tumor DNA | Neoadjuvant

China
St. Jude Children's Research Hospital

Not yet recruiting

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

High-risk Neuroblastoma

United States
OBI Pharma, Inc

Recruiting

A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

United States
The Christie NHS Foundation Trust

Not yet recruiting

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy (ClearED)

Head and Neck Cancer | Nasopharyngeal Carcinoma | Nasopharyngeal Cancer | Epstein-Barr Virus
Veerle Ruijters
ZonMw: The Netherlands Organisation for Health Research and Development; Curium...

Not yet recruiting

FET-PET-Guided Management of Pseudoprogression in Glioblastoma (FET-POPPING)

Glioblastoma | Radionecrosis of Brain

Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.

Not yet recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors
University of Virginia

Not yet recruiting

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer (Panc 002)

Pancreatic Cancer | Pancreas Cancer
National Cancer Institute (NCI)

Not yet recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Somatostatin Receptor Positive | Head and Neck Tumors | Small Cell Lung Cancers | Gastrointestinal Neuroendocrine Tumors | Pheochromocytoma/Paragangliomas | Kidney Cancers

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
M.D. Anderson Cancer Center; Mayo Clinic; Royal Marsden NHS Foundation Trust; McGill... and other collaborators

Not yet recruiting

High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma (SARveillance)

Sarcoma,Soft Tissue | Sarcoma Retroperitoneal

United Kingdom, Italy
Institut de cancérologie Strasbourg Europe
LEAF4Life, Inc.

Not yet recruiting

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients (THREE-GLEES)

Glioblastoma

France
RenJi Hospital

Recruiting

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer

Tumor Pancreas

China
Lipomedix Pharmaceuticals Inc.

Recruiting

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Cancer of Pancreas | Cancer of Ovary

Israel

Search clinical trials for: Tumor Regression

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations